The United Laboratories International Holdings Limited (HKG:3933)

78.02% (1Y)

Market Cap	26.49B
Revenue (ttm)	14.64B
Net Income (ttm)	2.83B
Shares Out	1.82B
EPS (ttm)	1.56
PE Ratio	9.36
Forward PE	6.93
Dividend	0.61 (4.20%)
Ex-Dividend Date	Jul 8, 2025

Volume	65,340,080
Average Volume	14,209,547
Open	14.82
Previous Close	15.38
Day's Range	14.22 - 14.82
52-Week Range	7.97 - 17.90
Beta	0.12
RSI	45.99
Earnings Date	Aug 29, 2025

About HKG:3933

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 17,000
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 3933

Financial Performance

In 2024, HKG:3933's revenue was 13.76 billion, an increase of 0.14% compared to the previous year's 13.74 billion. Earnings were 2.66 billion, a decrease of -1.54%.

Financial numbers in CNY